Naari Pharma Private Limited, a Bengaluru-based vertically integrated women’s health pharma business focused on hormones, announced that it has entered into a definitive asset purchase agreement to acquire 10 Abbreviated New Drug Applications (ANDAs) for the U.S. market from Intas Pharmaceuticals Ltd. The portfolio acquired comprises eight U.S. FDA approved ANDAs and two products pending…